Correlation Between Neuroone Medical and Heart Test

Can any of the company-specific risk be diversified away by investing in both Neuroone Medical and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuroone Medical and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuroone Medical Technologies and Heart Test Laboratories, you can compare the effects of market volatilities on Neuroone Medical and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuroone Medical with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuroone Medical and Heart Test.

Diversification Opportunities for Neuroone Medical and Heart Test

0.27

Correlation Coefficient

Neuroone Medical  Heart Test

Modest diversification

The 3 months correlation between Neuroone and Heart is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Neuroone Medical Technologies and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and Neuroone Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuroone Medical Technologies are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of Neuroone Medical i.e., Neuroone Medical and Heart Test go up and down completely randomly.

Pair Corralation between Neuroone Medical and Heart Test

Given the investment horizon of 90 days Neuroone Medical Technologies is expected to under-perform the Heart Test. But the stock apears to be less risky and, when comparing its historical volatility, Neuroone Medical Technologies is 1.51 times less risky than Heart Test. The stock trades about -0.03 of its potential returns per unit of risk. The Heart Test Laboratories is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  294.00  in Heart Test Laboratories on September 23, 2024 and sell it today you would earn a total of  89.00  from holding Heart Test Laboratories or generate 30.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neuroone Medical Technologies  vs.  Heart Test Laboratories

Neuroone Medical Tec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neuroone Medical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Heart Test Laboratories

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Heart Test Laboratories are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady fundamental indicators, Heart Test unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neuroone Medical and Heart Test

The main advantage of trading using opposite Neuroone Medical and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuroone Medical position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.

The idea behind Neuroone Medical Technologies and Heart Test Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.